2003
DOI: 10.1016/s0952-3278(03)00088-7
|View full text |Cite
|
Sign up to set email alerts
|

Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
12
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 26 publications
3
12
0
Order By: Relevance
“…This increase may be due to the poor antioxidant capacity as a consequence of low GSH and AA levels. These results are in accordance with some previous studies concerning diabetic tissues (Bhor et al, 2004;Gumieniczek, 2005;Yawuz et al, 2003).…”
Section: Discussionsupporting
confidence: 94%
“…This increase may be due to the poor antioxidant capacity as a consequence of low GSH and AA levels. These results are in accordance with some previous studies concerning diabetic tissues (Bhor et al, 2004;Gumieniczek, 2005;Yawuz et al, 2003).…”
Section: Discussionsupporting
confidence: 94%
“…Angiotensin converting enzyme (ACE) inhibitors, because of their protective effects for the cardiovascular system and kidney, are regarded as first-line antihypertensive drugs for patients with diabetes (World Health Organization, 1999). Mechanisms that account for the protective effects of ACE inhibitors on diabetesinduced vascular dysfunction are not fully known, but they are probably related to increased insulin sensitivity (Torlone et al, 1993), inhibition of oxidative stress (Yayuz et al, 2003), and modulation of the NO pathway (Rajagoplan and Harrison, 1996). In the present investigation, we report the effect of diabetes on aortic NO in SHR and the possible modulation of this effect by the administration of captopril.…”
Section: Introductionmentioning
confidence: 71%
“…To evaluate the effects of GbE on DN, in our present work we used captopril (CAP) as an antifibrotic control drug [9,10] , and studied the possible influences of GbE on the parameters that indicate protective effects against the progress of DN, such as blood glucose, AGE, TGF-β1, MMP-2, TIMP-2, CTGF, collagen IV and laminin in the kidney cortex, anti-oxidases in the serum, and the thickness of the glomerular base membrane (GBM) on early experimental DN rats, and observed the morphological changes on DN rats. Induction of DN model and study protocol Diabetes mellitus was induced in the male Sprague-Dawley rats, by ip injection of 60 mg/kg of the beta-cell toxin STZ (dissolved in pH 4.5 citrate buffer immediately before the injection), while controlled normal standard rats (NS group, n=13) received 6 mL/kg citrate buffer.…”
Section: Introductionmentioning
confidence: 99%